Cargando…
Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment
Novel Coronavirus infection (COVID-19) has become a pandemic in these days. It is an acute respiratory and infectious disease with no known etiology and treatment. It is continuously causing losses of precious lives and economy at a global scale on daily basis. It is the need of the hour to find mor...
Autor principal: | Mehboob, Riffat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435369/ https://www.ncbi.nlm.nih.gov/pubmed/34536760 http://dx.doi.org/10.1016/j.biopha.2021.112159 |
Ejemplares similares
-
Substance P/Neurokinin 1 and Trigeminal System: A Possible Link to the Pathogenesis in Sudden Perinatal Deaths
por: Mehboob, Riffat
Publicado: (2017) -
Enhanced Neurokinin-1 Receptor Expression Is Associated with Human Dental Pulp Inflammation and Pain Severity
por: Mehboob, Riffat, et al.
Publicado: (2021) -
Prognostic Significance of Substance P/Neurokinin 1 Receptor and Its Association with Hormonal Receptors in Breast Carcinoma
por: Mehboob, Riffat, et al.
Publicado: (2021) -
Substance P/ Neurokinin-1 Receptor, Trigeminal Ganglion, Latency, and Coronavirus Infection-Is There Any Link?
por: Mehboob, Riffat, et al.
Publicado: (2021) -
Elevated Neurokinin-1 Receptor Expression in Uterine Products of Conception Is Associated With First Trimester Miscarriages
por: Alwazzan, Ahmad, et al.
Publicado: (2020)